Trifluperidol hydrochloride
SIGMA/T103
Synonym: 4′-Fluoro-4-[4-hydroxy-4-(α,α,α-trifluoro-m tolyl)
CAS Number: 2062-77-3
Empirical Formula (Hill Notation): C22H23F4NO2 · HCl
Molecular Weight: 445.88
EC Number: 218-170-1
MDL Number: MFCD00055195
Linear Formula: C22H23F4NO2 · HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | solid |
| InChI | 1S/C22H23F4NO2.ClH/c23-19 |
| InChI key | VYGQXRZAHIZHQV-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Cl.OC1(CCN(CCCC(=O)c2ccc( |
| solubility | DMSO: ≥20 mg/mL |
| ethanol: moderately soluble | |
| H2O: soluble | |
| storage condition | desiccated |
| Application: | The interaction of Trifluperidol hydrochloride with NMDA receptors was studied in rat brain buffy coat membranes. |
| Biochem/physiol Actions: | Trifluperidol is a dopamine receptor antagonist with antipsychotic effects used in the treatment of schizophrenia. This neuroleptic penetrates the brain and also affects the glial cells leading to increased release of proinflammatory cytokines. It also alters the metabolism of carbohydrates and amino acids in the brain cortex. |
| Packaging: | 25, 100 mg in glass bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P264 - P270 - P301 + P310 - P405 - P501 |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 22-36/37/39-45 |
| RIDADR | UN 2811 6.1 / PGII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| UNSPSC | 12352200 |


